StockWatch
·
Pharmaceuticals
Board Meeting19 May 2026, 06:41 pm

Viyash Scientific Approves FY26 Audited Results & ESOPs

AI Summary

Viyash Scientific Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. They also adopted new Articles of Association, subject to shareholder approval, and granted 1,30,98,000 stock options to eligible employees under the "Viyash Scientific Limited Employee Stock Option Scheme 2026." No dividend was recommended for FY 2025-26. The meeting concluded at 4:56 p.m.

Key Highlights

  • Audited standalone and consolidated financial results for FY26 approved.
  • New Articles of Association adopted, pending shareholder approval.
  • 1,30,98,000 stock options granted under ESOP 2026.
  • No dividend recommended for FY 2025-26.
  • Board Meeting concluded at 4:56 p.m.